around hydroxychloroquine, the reason there was hype, could you give something to people who were mildly, moderately ill, a pill they could take at home and prevent them from going to the hospital. everybody thought it is a pipe dream, remdesivir came close, but further trial results did not show it as promising. hydroxychloroquine was problematic, harmful to patients. monoclonal antibodies was the only thing that could do that, requires an infusion, about 2,000 bucks a dose. here you talk about five days, twice a day of a pill that could potentially what it does, it basically interferes with how the virus replicates. you have the virus in your body, it is replicating, this comes in and in various ways stops that replication process from happening. so if it works, and, again, lots of ifs here, because the fda has to look at this, remdesivir had a lot of promise as well. this sounds really promising,